85 related articles for article (PubMed ID: 14648614)
21. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
Lepsík M; Kríz Z; Havlas Z
Proteins; 2004 Nov; 57(2):279-93. PubMed ID: 15340915
[TBL] [Abstract][Full Text] [Related]
22. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Huang SY; Zou X
Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
[TBL] [Abstract][Full Text] [Related]
23. A strategy for predicting the crystal structures of flexible molecules: the polymorphism of phenobarbital.
Day GM; S Motherwell WD; Jones W
Phys Chem Chem Phys; 2007 Apr; 9(14):1693-704. PubMed ID: 17396181
[TBL] [Abstract][Full Text] [Related]
24. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
Jenwitheesuk E; Samudrala R
Antivir Ther; 2005; 10(1):157-66. PubMed ID: 15751773
[TBL] [Abstract][Full Text] [Related]
25. Improving amino-acid identification, fit and C(alpha) prediction using the Simplex method in automated model building.
Romo TD; Sacchettini JC; Ioerger TR
Acta Crystallogr D Biol Crystallogr; 2006 Nov; 62(Pt 11):1401-6. PubMed ID: 17057345
[TBL] [Abstract][Full Text] [Related]
26. Rigid backbone moiety of KNI-272, a highly selective HIV protease inhibitor: methanol, acetone and dimethylsulfoxide solvated forms of 3-[3-benzyl-2-hydroxy-9-(isoquinolin-5-yloxy)-6-methylsulfanylmethyl-5,8-dioxo-4,7-diazanonanoyl]-N-tert-butyl-1,3-thiazolidine-4-carboxamide.
Doi M; Kimura T; Ishida T; Kiso Y
Acta Crystallogr B; 2004 Aug; 60(Pt 4):433-7. PubMed ID: 15258401
[TBL] [Abstract][Full Text] [Related]
27. Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design.
Zauhar RJ; Moyna G; Tian L; Li Z; Welsh WJ
J Med Chem; 2003 Dec; 46(26):5674-90. PubMed ID: 14667221
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains.
Smith AB; Charnley AK; Harada H; Beiger JJ; Cantin LD; Kenesky CS; Hirschmann R; Munshi S; Olsen DB; Stahlhut MW; Schleif WA; Kuo LC
Bioorg Med Chem Lett; 2006 Feb; 16(4):859-63. PubMed ID: 16298527
[TBL] [Abstract][Full Text] [Related]
29. Alignment of three-dimensional molecules using an image recognition algorithm.
Richmond NJ; Willett P; Clark RD
J Mol Graph Model; 2004 Oct; 23(2):199-209. PubMed ID: 15363461
[TBL] [Abstract][Full Text] [Related]
30. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
[TBL] [Abstract][Full Text] [Related]
31. Towards a MIP-based alignment and docking in computer-aided drug design.
Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
[TBL] [Abstract][Full Text] [Related]
32. Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations.
Maass P; Schulz-Gasch T; Stahl M; Rarey M
J Chem Inf Model; 2007; 47(2):390-9. PubMed ID: 17305328
[TBL] [Abstract][Full Text] [Related]
33. Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality.
Lu D; Vince R
Bioorg Med Chem Lett; 2007 Oct; 17(20):5614-9. PubMed ID: 17822899
[TBL] [Abstract][Full Text] [Related]
34. Comparing the conformational behavior of a series of diastereomeric cyclic urea HIV-1 inhibitors using the low mode:monte carlo conformational search method.
Parish CA; Yarger M; Sinclair K; Dure M; Goldberg A
J Med Chem; 2004 Sep; 47(20):4838-50. PubMed ID: 15369387
[TBL] [Abstract][Full Text] [Related]
35. Adaptive inhibitors of the HIV-1 protease.
Ohtaka H; Freire E
Prog Biophys Mol Biol; 2005 Jun; 88(2):193-208. PubMed ID: 15572155
[TBL] [Abstract][Full Text] [Related]
36. Protein secondary structure assignment through Voronoï tessellation.
Dupuis F; Sadoc JF; Mornon JP
Proteins; 2004 May; 55(3):519-28. PubMed ID: 15103616
[TBL] [Abstract][Full Text] [Related]
37. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
38. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
Marrero-Ponce Y
J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
[TBL] [Abstract][Full Text] [Related]
39. Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease.
Klon AE; Glick M; Davies JW
J Chem Inf Comput Sci; 2004; 44(6):2216-24. PubMed ID: 15554692
[TBL] [Abstract][Full Text] [Related]
40. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
